世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ナイジェリアの皮膚科

ナイジェリアの皮膚科


Dermatologicals in Nigeria

ナイジェリアでは、気候変動によってますます顕著になっている気候や、汚れた環境のために、皮膚疾患がよく見られます。これらの皮膚疾患が引き起こす身体的感覚だけでなく、その見え方の心理的影響から、生活の... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Euromonitor International
ユーロモニターインターナショナル
2022年2月7日 US$650
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
お問合わせください 24 英語

 

サマリー

ナイジェリアでは、気候変動によってますます顕著になっている気候や、汚れた環境のために、皮膚疾患がよく見られます。これらの皮膚疾患が引き起こす身体的感覚だけでなく、その見え方の心理的影響から、生活の質に与える影響は甚大です。皮膚疾患は、ナイジェリアで最も多く見られる健康問題の一つであり、公衆衛生上の大きな負担となっています。可処分所得の増加や生活習慣の多様化により、皮膚疾患への関心は高まっています。

Euromonitor Internationalの調査レポート「ナイジェリアの皮膚科」は、国レベルの市場規模と形状に関する包括的なガイドを提供しています。2017-2021年の最新小売販売データを提供し、成長を促進する部門を特定することができます。2026年までの予測では、市場がどのように変化していくかを示しています。

製品のカバー範囲抗寄生虫剤/シラミ(頭・体)治療薬、鎮痒剤、冷え症治療薬、痔治療薬、脱毛治療薬、薬用シャンプー、おむつかぶれ治療薬、小児用皮膚科、局所アレルギー治療薬/抗ヒスタミン剤、局所防かび剤、局所殺菌/防腐剤、膣防かび剤。

データ範囲:市場規模(過去および予測)、企業シェア、ブランドシェア、流通データ。

本レポートを購入する理由
* 皮膚科市場の詳細なイメージを得ることができます。
* 成長分野を特定し、変化を促す要因を特定する。
* 競争環境、市場の主要プレーヤー、主要ブランドを理解する。
* 5年後を予測することで、市場の発展予測を評価することができます。

ユーロモニター・インターナショナルは、市場調査レポート、ビジネス参考書、オンライン情報システムの出版で40年以上の経験を有しています。ロンドン、シカゴ、シンガポール、上海、ビリニュス、ドバイ、ケープタウン、サンティアゴ、シドニー、東京、バンガロールにオフィスを構え、世界中に800人を超えるアナリストのネットワークを持つユーロモニター・インターナショナルは、情報に基づいた戦略立案を支援する信頼できる情報資源を開発する独自の能力を有しています。


ページTOPに戻る


目次

Dermatologicals in Nigeria
Euromonitor International
February 2022

List Of Contents And Tables

DERMATOLOGICALS IN NIGERIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Numerous opportunities for market growth
Environmental factors drive sale of paediatric dermatologicals
Neimeth International Pharmaceuticals leads dermatologicals
PROSPECTS AND OPPORTUNITIES
Topical antifungals expected to continue to lead sales
High birth rate will continue to drive demand for nappy (diaper) rash remedies.
Competition expected to intensify as brands focus on innovation, consumer awareness and channel expansion
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2016-2021
Table 2 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 4 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 5 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN NIGERIA
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
NAFDAC specifies minimum labelling requirements that must be met prior to full registration. These are summarised as follows:
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

 

ページTOPに戻る


 

Summary

Skin disorders are common in Nigeria due to the climate – an increasingly significant factor due to climate change – and dirty environments. The impact of these skin conditions on quality of life can be enormous, not only from the physical sensations they cause but also from the psychological effects of their visibility. Skin disorders are amongst the most commonly presenting health problems in Nigeria and pose a significant public health burden. Increases in disposable income and the accelerati...

Euromonitor International's Dermatologicals in Nigeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.



ページTOPに戻る


Table of Contents

Dermatologicals in Nigeria
Euromonitor International
February 2022

List Of Contents And Tables

DERMATOLOGICALS IN NIGERIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Numerous opportunities for market growth
Environmental factors drive sale of paediatric dermatologicals
Neimeth International Pharmaceuticals leads dermatologicals
PROSPECTS AND OPPORTUNITIES
Topical antifungals expected to continue to lead sales
High birth rate will continue to drive demand for nappy (diaper) rash remedies.
Competition expected to intensify as brands focus on innovation, consumer awareness and channel expansion
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2016-2021
Table 2 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 4 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 5 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN NIGERIA
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
NAFDAC specifies minimum labelling requirements that must be met prior to full registration. These are summarised as follows:
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Euromonitor International社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630